<VariationArchive RecordType="classified" VariationID="224727" VariationName="NM_025207.5(FLAD1):c.1484_1486del (p.Ser495del)" VariationType="Deletion" Accession="VCV000224727" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-07-29" DateCreated="2016-06-04" MostRecentSubmission="2019-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="226517" VariationID="224727">
      <GeneList>
        <Gene Symbol="FLAD1" FullName="flavin adenine dinucleotide synthetase 1" GeneID="80308" HGNC_ID="HGNC:24671" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="154983344" stop="154993111" display_start="154983344" display_stop="154993111" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="154955769" stop="154965586" display_start="154955769" display_stop="154965586" Strand="+" />
          </Location>
          <OMIM>610595</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025207.5(FLAD1):c.1484_1486del (p.Ser495del)</Name>
      <CanonicalSPDI>NC_000001.11:154990455:CTCCT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="154990456" stop="154990458" display_start="154990456" display_stop="154990458" variantLength="3" positionVCF="154990455" referenceAlleleVCF="ACTC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="154962932" stop="154962934" display_start="154962932" display_stop="154962934" variantLength="3" positionVCF="154962931" referenceAlleleVCF="ACTC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S495del</ProteinChange>
      <ProteinChange>S398del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.154962934_154962936del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.154962934_154962936del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.154990458_154990460del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.154990458_154990460del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042310.1" sequenceAccession="NG_042310" sequenceVersion="1" change="g.12165_12167del">
            <Expression>NG_042310.1:g.12165_12167del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001184891.2" sequenceAccession="NM_001184891" sequenceVersion="2" change="c.1193_1195del">
            <Expression>NM_001184891.2:c.1193_1195del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171820.1" sequenceAccession="NP_001171820" sequenceVersion="1" change="p.Ser398del">
            <Expression>NP_001171820.1:p.Ser398del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025207.5" sequenceAccession="NM_025207" sequenceVersion="5" change="c.1484_1486del" MANESelect="true">
            <Expression>NM_025207.5:c.1484_1486del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079483.3" sequenceAccession="NP_079483" sequenceVersion="3" change="p.Ser495del">
            <Expression>NP_079483.3:p.Ser495del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201398.3" sequenceAccession="NM_201398" sequenceVersion="3" change="c.1193_1195del">
            <Expression>NM_201398.3:c.1193_1195del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958800.1" sequenceAccession="NP_958800" sequenceVersion="1" change="p.Ser398del">
            <Expression>NP_958800.1:p.Ser398del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10575996" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610595.0002" DB="OMIM" />
        <XRef Type="rs" ID="876661309" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025207.5(FLAD1):c.1484_1486del (p.Ser495del) AND Multiple acyl-CoA dehydrogenase deficiency" Accession="RCV000223940" Version="2">
        <ClassifiedConditionList TraitSetID="3248">
          <ClassifiedCondition DB="MedGen" ID="C0268596">Multiple acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-03-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025207.5(FLAD1):c.1484_1486del (p.Ser495del) AND Myopathy with abnormal lipid metabolism" Accession="RCV000234840" Version="3">
        <ClassifiedConditionList TraitSetID="31164">
          <ClassifiedCondition DB="MedGen" ID="C4310822">Myopathy with abnormal lipid metabolism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-09-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-03-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-06-04" MostRecentSubmission="2019-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27259049</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="31164" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3417" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myopathy with abnormal lipid metabolism</ElementValue>
                <XRef ID="MONDO:0009703" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LSMFLAD</ElementValue>
                <XRef Type="MIM" ID="255100" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310822" DB="MedGen" />
              <XRef ID="MONDO:0009703" DB="MONDO" />
              <XRef Type="MIM" ID="255100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3248" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5563" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ethylmalonic-adipicaciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric aciduria, type 2</ElementValue>
                <XRef ID="Glutaric+Acidemia+II/3111" DB="Genetic Alliance" />
                <XRef ID="22886006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0009282" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA II</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EMA</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MADD</ElementValue>
                <XRef Type="MIM" ID="231680" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenital anomalies), and type III (late onset). Individuals with type I or II MADD typically become symptomatic in the neonatal period with severe metabolic acidosis, which may be accompanied by profound hypoglycemia and hyperammonemia. Many affected individuals die in the newborn period despite metabolic treatment. In those who survive the neonatal period, recurrent metabolic decompensation resembling Reye syndrome and the development of hypertrophic cardiomyopathy can occur. Congenital anomalies may include dysmorphic facial features, large cystic kidneys, hypospadias and chordee in males, and neuronal migration defects (heterotopias) on brain MRI. Individuals with type III MADD, the most common presentation, can present from infancy to adulthood. The most common symptoms are muscle weakness, exercise intolerance, and/or muscle pain, although metabolic decompensation with episodes of rhabdomyolysis can also be seen. Rarely, individuals with late-onset MADD (type III) may develop severe sensory neuropathy in addition to proximal myopathy.</Attribute>
                <XRef ID="NBK558236" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6523" />
                <XRef ID="6523" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32550677</ID>
                <ID Source="BookShelf">NBK558236</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Glutaric-Aciduria-Type-2-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 and C5 +/- Other Acylcarnitines, Glutaric Acidemia II (GA-II) (MADD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm,">
                <URL>https://www.acmg.net/PDFLibrary/C4-C5-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Glutaric Acidemia II (GA-II)/ MADD, Riboflavin Metabolism Disorder, Ethylmalonic Encephalopathy: C4 and C5 elevated +/- other elevated acylcarnitines (AC), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C8 with Lesser Elevations of C6 and C10 Acylcarnitine, Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/C8-C6-C10-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C8 Elevated + Lesser Elevations of C6 and C10, 2021</CitationText>
              </Citation>
              <XRef ID="26791" DB="Orphanet" />
              <XRef ID="C0268596" DB="MedGen" />
              <XRef ID="MONDO:0009282" DB="MONDO" />
              <XRef Type="MIM" ID="231680" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="498946" SubmissionDate="2016-03-15" DateLastUpdated="2016-06-04" DateCreated="2016-06-04">
        <ClinVarSubmissionID localKey="NM_025207.4:c.1484_1486delCCT|OMIM:231680" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000266355" DateUpdated="2016-06-04" DateCreated="2016-06-04" Type="SCV" Version="2" SubmitterName="Research Unit for Molecular Medicine, Department for Clinical Medicine, Aarhus University" OrgID="505750" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">27259049</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">27259049</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025207.4:c.1484_1486delCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="231680" Type="MIM" />
          </Trait>
          <Comment>Multiple acyl-CoA dehydrogenase and combined respiratory chain deficiency</Comment>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">27259049</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27259049</ID>
        </Citation>
        <StudyDescription>A multicenter study describing FLAD1 variants in affected families derived from metabolic centers in six countries</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>FLAD1study</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="556383" SubmissionDate="2019-09-10" DateLastUpdated="2019-09-16" DateCreated="2016-07-03">
        <ClinVarSubmissionID localKey="610595.0002_LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY" title="FLAD1, 3-BP DEL, 1484CCT_LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000292022" DateUpdated="2019-09-16" DateCreated="2016-07-03" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, born of consanguineous Turkish parents, with lipid storage myopathy due to FLAD1 deficiency (LSMFLAD; 255100), Olsen et al. (2016) identified a homozygous in-frame 3-bp deletion (c.1484_1486delCCT, NM_025207.4) in exon 5 of the FLAD1 gene, resulting in the deletion of a highly conserved residue (Ser495del) in the FADS domain. The mutation, which was found by sequencing of candidate genes, segregated with the disorder in the family and was not found in the ExAC database or in an in-house exome database of 6,000 individuals. Patient cells showed normal amounts of FADS2 protein, but only about 50% residual FAD synthesis activity. One of the patients died at age 3 days, whereas the other was alive at age 22 years and showed a good response to riboflavin treatment.</Attribute>
              <Citation>
                <ID Source="PubMed">27259049</ID>
              </Citation>
              <XRef DB="OMIM" ID="255100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLAD1" />
          </GeneList>
          <Name>FLAD1, 3-BP DEL, 1484CCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1484CCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610595.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="556383" TraitType="Disease" MappingType="Name" MappingValue="LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C4310822" Name="Myopathy with abnormal lipid metabolism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="498946" TraitType="Disease" MappingType="XRef" MappingValue="231680" MappingRef="OMIM">
        <MedGen CUI="C0268596" Name="Multiple acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

